Exclusive: Developer claims Yang suggested meeting with Kim Seung-won and him
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
- Genencell founder Kang claimed that Yang suggested a meeting with Justice Minister nominee Kim Seung-won in October 2021.
- Kang said he did not meet Kim because he feared the encounter could be misunderstood.
- He also claimed Yang highlighted personal ties with lawmakers from both the Democratic Party and the People Power Party.
The founder of Genencell, a developer of a COVID-19 treatment, has claimed that Yang suggested a meeting involving him and Kim Seung-won, the nominee for justice minister.
Yang mentioned Kim first and suggested that the three of us meet.
Kang told the Dong-A Ilbo on September 7 that Yang first mentioned Kim around October 2021 and proposed that the three meet. Yang allegedly said it would be good for them to get to know one another.
It would be good for us to get to know one another.
Kang said he initially considered having a meal with Kim, who was then an acquaintance of Yang, but changed his mind after deciding the meeting could be misunderstood. He said the meeting never took place.
I initially thought we could just have a meal with Kim, but then I thought it could be misunderstood, so we did not actually meet.
South Koreaโs Ministry of Food and Drug Safety approved Genencellโs clinical trial in October 2021. Kang also claimed Yang spoke of close ties with many People Power Party lawmakers, saying the people Yang called โolder brothersโ included numerous lawmakers from both the Democratic Party and the People Power Party. The article also notes that Kim received 5 million won in donations.
The people Yang called โolder brothersโ included many lawmakers from the Democratic Party as well as the People Power Party.
Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.